Company Overview and News

0
RMP / Rice Midstream Partners LP DEFM14A

23h sec.gov
Use these links to rapidly review the document TABLE OF CONTENTS TABLE OF CONTENTS
RMP

0
Options Traders Expect Huge Moves in Rice Midstream Partners (RMP) Stock

2018-06-19 zacks
Investors in Rice Midstream Partners LP (RMP - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Jul 20, 2018 $30.00 Put had some of the highest implied volatility of all equity options today.
RMP

8
EQT Midstream Partners: To Wait Or Not To Wait

2018-06-18 seekingalpha
My investment club will have its shares of Rice Midstream converted to EQT Midstream in the third quarter of 2018.
EQM EQT CNX.WI RMP HESM CNXM RICE

0
RMP / Rice Midstream Partners LP / Salient Capital Advisors, LLC - null (Passive Investment)

2018-06-08 sec.gov
UNITED STATES* SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.1)* Rice Midstream Partners LP ------------------------------------------------ (Name of Issuer) Common Units Representing Limited Partner Interests ------------------------------ (Title of Class of Securities) 7
RMP

0
RMP / Rice Midstream Partners LP / Salient Capital Advisors, LLC - null (Passive Investment)

2018-06-08 sec.gov
UNITED STATES* SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.1)* Rice Midstream Partners LP ------------------------------------------------ (Name of Issuer) Common Units Representing Limited Partner Interests ------------------------------ (Title of Class of Securities) 7
RMP

10
Which Energy Stocks Outperformed Oil’s Fall Last Week?

2018-05-29 marketrealist
Between May 18 and May 25, the SPDR S&P Oil & Gas Exploration & Production ETF (XOP) fell 5.3%—the second-largest decline among the major energy subsector ETFs that we discussed in the previous part of this series.
AM EQM RMP

43
Master Limited Partnership Simplifications On The Rise

2018-05-18 seekingalpha
The three only mark an acceleration of the trend of MLP "roll-ups," however. Many others have been announced in 2018.
ARLP LGCYP APLP LGCYO CQP EBGUF RMP AROC ENB TEP TEGP SEP NSH EQM WPZ WMB EQGP EEP LNG BWP L ENB ENF LGCY

364
Implied Volatility Surging for Rice Midstream (RMP) Stock Options

2018-05-11 zacks
Investors in Rice Midstream Partners LP (RMP - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the May 18, 2018 $30 Put had some of the highest implied volatility of all equity options today.
RMP AAOI

114
Trump Nixes Iran Nuclear Deal: Winners & Losers

2018-05-09 zacks
The United States has pulled out of the landmark deal curbing Iran’s nuclear program and reimposing sanctions on the Islamic Republic. Trump said that it was a “horrible one-sided deal that should have never, ever been made.” He added that the “Iran deal is defective at its core” and it’s an “embarrassment” that the United States did little to restrain Iran’s nuclear ambition.
APC OMP ECN EPM XOM HES RMP VLO ECA EPM-A PES HES.PRA ECA BOE CVX MYGN OXY BA AEUA

17
Is Self-Funding An MLP Pipe Dream?

2018-05-09 seekingalpha
Self-funding has become a buzzword in the MLP space, but is it really translating to MLPs’ capital plans? Admittedly, the shift to self-funding is still in early innings, and the transition will take time. That said, it seems like a logical next step as the MLP space continues to mature. In today’s post, we discuss the impetus behind MLPs’ shift to self-funding and give some examples of MLPs that are pursuing self-funding.
MPLX DCP RMP EPD MPC ALJ GNE EQM ALDW WES GNE MMP GEL

3
Oil Hits $70 for First Time in 4 Years: 5 Top Energy Picks

2018-05-08 zacks
A cut in global oil output initiated by OPEC and other major oil producers, including Russia, has helped prices more than double from the collapse in early 2016. Venezuela’s production woes drove the rally as well.
NINE OMP EPM RMP EPM-A PES

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

7h - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

8h - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

Silicon Investor Message Boards

This table lists all message boards related to RMP / Rice Midstream Partners LP on message board site Silicon Investor.

URMP BLACK GOLD X_RAMP.COM, INC. (OTCBB : XRMP)
CUSIP: 762819100